PhRMA CEO: Ubl Pick Would Bring User Fee, Reimbursement Expertise
This article was originally published in The Pink Sheet Daily
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.
You may also be interested in...
Chip Davis still believes in innovation, but now must balance that with affordability in new role leading the generic association.
John Castellani will step down at the end of the year as president and CEO of PhRMA after leading the association since September 2010.
Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.